Koninklijke Vopak NV (0O8V)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 53.78 |
|---|---|
| 52-week range | 36.56 – 53.78 |
| Return, 1 month / 3 months | +13.3% / +16.1% |
| Return, 1 year / 3 years | +34.4% / +83.1% |
| Trend | Uptrend |
| RSI (14) | 74 |
| Volatility (1 year) | 22.1% |
| Worst drawdown (1 year) | -15.5% |
| Average daily value traded | 1.26M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Koninklijke Vopak NV is a Dutch company based in Rotterdam that stores and handles bulk liquids at tank terminals. It provides storage, transshipment and related logistics services for oil products, chemicals, gases and other bulk liquid goods. Its customers are mainly companies in the oil, chemical and gas industries that need safe places to keep and move their products, and it runs terminal facilities in ports and industrial areas in several countries.
The shares are listed on the London Stock Exchange in UK under the code 0O8V, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Koninklijke Vopak NV (0O8V) trades on the London Stock Exchange in UK. It last closed at EUR 53.78 on 27 October 2026.
Its price-based Market X-Ray is 78 out of 100 (a strong price profile), ranking 112 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 34.4% and over the last three months it rose 16.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 85 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 16.5% | ||
| From 52-week high | 0.0% | ||
| Momentum | 81 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 16.1% | ||
| 6-month return | 30.5% | ||
| 12-month return, skipping the last month | 18.6% | ||
| Stability (higher is calmer) | 84 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 22.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.5% | ||
| Liquidity | 55 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.26M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +0.7% |
|---|---|
| 1 month | +13.3% |
| 3 months | +16.1% |
| 6 months | +30.5% |
| 1 year | +34.4% |
| 3 years | +83.1% |
| 5 years | +83.0% |
Signals
| 50-day / 200-day average | 49.22 / 46.15 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.99 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Apr 2025 | EUR 1.6000 |
| 26 Apr 2024 | EUR 1.5000 |
| 28 Apr 2023 | EUR 1.3000 |
| 22 Apr 2022 | EUR 1.2500 |
| 23 Apr 2021 | EUR 1.2000 |
| 23 Apr 2020 | EUR 1.1500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.